↓ Skip to main content

Survivin selective inhibitor YM155 induce apoptosis in SK-NEP-1 Wilms tumor cells

Overview of attention for article published in BMC Cancer, December 2012
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Citations

dimensions_citation
39 Dimensions

Readers on

mendeley
34 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Survivin selective inhibitor YM155 induce apoptosis in SK-NEP-1 Wilms tumor cells
Published in
BMC Cancer, December 2012
DOI 10.1186/1471-2407-12-619
Pubmed ID
Authors

Yan-Fang Tao, Jun Lu, Xiao-Juan Du, Li-Chao Sun, Xuan Zhao, Liang Peng, Lan Cao, Pei-Fang Xiao, Li Pang, Dong Wu, Na Wang, Xing Feng, Yan-Hong Li, Jian Ni, Jian Wang, Jian Pan

Abstract

Survivin, a member of the family of inhibitor of apoptosis proteins, functions as a key regulator of mitosis and programmed cell death. YM155, a novel molecular targeted agent, suppresses survivin, which is overexpressed in many tumor types. The aim of this study was to determine the antitumor activity of YM155 in SK-NEP-1 cells.

Mendeley readers

The data shown below were compiled from readership statistics for 34 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Croatia 1 3%
Unknown 33 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 24%
Student > Master 5 15%
Student > Ph. D. Student 4 12%
Student > Doctoral Student 3 9%
Other 2 6%
Other 5 15%
Unknown 7 21%
Readers by discipline Count As %
Agricultural and Biological Sciences 9 26%
Medicine and Dentistry 6 18%
Chemistry 3 9%
Biochemistry, Genetics and Molecular Biology 2 6%
Sports and Recreations 1 3%
Other 4 12%
Unknown 9 26%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 December 2012.
All research outputs
#2,899,991
of 3,630,009 outputs
Outputs from BMC Cancer
#1,382
of 1,786 outputs
Outputs of similar age
#221,976
of 278,451 outputs
Outputs of similar age from BMC Cancer
#84
of 118 outputs
Altmetric has tracked 3,630,009 research outputs across all sources so far. This one is in the 2nd percentile – i.e., 2% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,786 research outputs from this source. They receive a mean Attention Score of 2.6. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 278,451 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 118 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.